EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Design of a pragmatic cluster randomized controlled trial: Reducing high risk polypharmacy using behavioral economics through electronic health records

Lucia C Petito, Jonathan Arnold, Mark W Friedberg, Tiffany Brown, Ji Young Lee, Yaw Peprah, Neelima Pathri, Timothy M Bober, Stephen Handler, Sara Bradley, Michael Schachter, Ryan Chmiel und 7 weitere

Contemporary Clinical Trials · 2026-12 · 171 · 108522

DOI: 10.1016/j.cct.2026.108522 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2026-12. Verfasst von Lucia C Petito und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Division of Biostatistics and Informatics, Feinberg School of Medicine, Northwestern University, Chicago, IL, Unit…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Inappropriate polypharmacy can lead to harms among older adults. Behavioral nudges delivered using decision support in electronic health records (EHR) may be a scalable way to reduce polypharmacy. The goal of the High-Risk PolyPharmacy (HRPP) trial is to evaluate the effectiveness of a 'commitment nudge' and a 'justification nudge' alone and in combination on reducing HRPP via a pragmatic, clinic-randomized trial among patients aged 65 years and older. METHODS/DESIGN: This 2 × 2 clinic-randomized factorial trial in primary care clinics in two health systems has four parallel arms: EHR commitment nudge, EHR justification nudge, both, or neither, all coupled with optional clinician education activities. Eligible patients are aged ≥65 years actively using ≥5 systemic, oral medications. The primary outcome is a composite of seven indicators of HRPP. Secondary outcomes include the individual components of HRPP and measures of health system burden: all-cause and adverse drug event-specific emergency department (ED) visits and ED visits followed by hospitalization. RESULTS: We used constrained randomization to produce balance between study arms for 124 primary care clinics comprising 804 clinicians. At randomization, the median (range) practice had 573 (326-947) eligible patients; the average clinic-level prevalence of HRPP among these patients was 30.0%. The 18-month intervention began in 2023-October and 2024-November at NM and UPMC, respectively. Data collection will end in 2026-April at NM and 2026-December at UPMC. CONCLUSIONS: This trial is evaluating the effectiveness and safety of EHR-embedded interventions to reduce HRPP. If successful, this intervention could offer a low-cost, scalable solution. CLINICAL TRIALS REGISTRATION NUMBER: NCT05656560.

Schlagwörter

Stichwörter der Autor:innen

Cluster randomized trial protocolFactorial designGeriatricsHigh risk polypharmacyOvertreatment

Autor:innen und Institutionen

  • Department of Preventive Medicine, Division of Biostatistics and Informatics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America. Electronic address: lucia.petito@northwestern.ed…
  • Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.
  • Blue Cross Blue Shield of Massachusetts, Boston, MA, United States of America; Department of Health Care Policy, Harvard Medical School, Boston, MA, United States of America.
  • Department of Medicine, Division of General Internal Medicine and Geriatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
  • Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
  • Information Systems, Northwestern Medicine, Chicago, IL, United States of America.

Förderung

  • National Institute on Aging

Zitieren

APA

Petito, L. C., Arnold, J., Friedberg, M. W., Brown, T., Lee, J. Y., Peprah, Y., Pathri, N., Bober, T. M., Handler, S., Bradley, S., Schachter, M., Chmiel, R., Sullivan, M., Doctor, J. N., Meeker, D., Goldstein, N., Fox, C. R., Linder, J. A., & Persell, S. D. (2026). Design of a pragmatic cluster randomized controlled trial: Reducing high risk polypharmacy using behavioral economics through electronic health records. Contemporary Clinical Trials, 171, 108522. https://doi.org/10.1016/j.cct.2026.108522

Vancouver

Petito LC, Arnold J, Friedberg MW, Brown T, Lee JY, Peprah Y, et al. Design of a pragmatic cluster randomized controlled trial: Reducing high risk polypharmacy using behavioral economics through electronic health records. Contemporary Clinical Trials. 2026;171:108522. doi:10.1016/j.cct.2026.108522

BibTeX
@article{Petito2026,
  author = {Petito, Lucia C and Arnold, Jonathan and Friedberg, Mark W and Brown, Tiffany and Lee, Ji Young and Peprah, Yaw and Pathri, Neelima and Bober, Timothy M and Handler, Stephen and Bradley, Sara and Schachter, Michael and Chmiel, Ryan and Sullivan, Mark and Doctor, Jason N and Meeker, Daniella and Goldstein, Noah and Fox, Craig R and Linder, Jeffrey A and Persell, Stephen D},
  title = {Design of a pragmatic cluster randomized controlled trial: Reducing high risk polypharmacy using behavioral economics through electronic health records},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  volume = {171},
  pages = {108522},
  doi = {10.1016/j.cct.2026.108522}
}
Kostenlos starten →